ARID1A GENE MUTATION
Clinical trials for ARID1A GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ARID1A GENE MUTATION trials appear
Sign up with your email to follow new studies for ARID1A GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope drug enters human testing for tough cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called JAB-2485 in adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will first determine the safest dose and then look for early signs that the drug can shrink tumors in spec…
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New Two-Drug combo tested for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, avelumab and M1774, can help control a specific type of recurrent endometrial (uterine) cancer that has a mutation in the ARID1A gene. It is for patients whose cancer has come back after prior treatment, including immunotherapy. …
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE2 • Sponsor: Panagiotis Konstantinopoulos, MD, PhD • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC